A Schedule 13D filing on July 3, 2026, disclosed that Bering Partners II, L.P. has taken a 6.9% stake in CalciMedica. This position was primarily established through a private placement that closed on June 25, 2026. In this placement, Bering II purchased 1,450,267 units at a price of $0.8033 per unit.
The investment from the venture capital firm is for general investment purposes. The units included common stock and warrants to purchase additional shares, subject to stockholder approval. This new stake provides CalciMedica with additional funding and a new institutional investor.